Stem Cell Innovations Files new Patent Application Regarding Pluripotent Stem Cell Production
News Jan 27, 2009
Stem Cell Innovations, Inc. announced that it has filed a new patent application for the production of pluripotent stem cells from primordial germ cells.
"We have been working for several years to develop a more effective method for producing stem cells from germ cells," said CEO James H. Kelly, PhD. "This filing was submitted to secure our intellectual property prior to publication in the scientific literature."
The Company has been developing PluriCells™ for use in drug discovery. "The method in this application provides for a substantial improvement in both the yield and quality of stem cells produced. It builds on our already strong IP position in germ cell-derived stem cells and will allow us to expand in new directions," explained Kelly.
Stem Cell Signaling Drives Mammary Gland DevelopmentNews
New research illuminates the biology of breast tissue development and may pave the way to new strategies for diagnosing or even treating cancer.READ MORE
Tissue Engineered Human Pancreas Cells Successfully Treat Diabetic MiceNews
Researchers tissue-engineered human pancreatic islets in a laboratory that develop a circulatory system, secrete hormones like insulin and successfully treat sudden-onset type 1 diabetes in transplanted mice.READ MORE
Comments | 0 ADD COMMENT
Epigenetics in the nervous system: development and disease
Oct 01 - Oct 03, 2018